Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

BioChain Institute and Molecular Instruments Announce Launch of HCR™ Verified Tissue for Advanced Research


News provided by

BioChain Institute Inc.

Dec 05, 2024, 14:05 ET

Share this article

Share toX

Share this article

Share toX


BioChain Institutes, Inc., a global leader in high-quality biosample resources, and Molecular Instruments® (MI), the inventor of the HCR™ Imaging technology, are excited to announce the launch of a new line of HCR™ Verified Tissue products. This innovative tissue resource offers researchers unparalleled accuracy and confidence in RNA-based experiments, enabling breakthroughs in molecular diagnostics, cancer research, and gene expression studies.

NEWARK, Calif., Dec. 5, 2024 /PRNewswire-PRWeb/ -- BioChain Institutes, Inc., a global leader in high-quality biosample resources, and Molecular Instruments® (MI), the inventor of the HCR™ Imaging technology, are excited to announce the launch of a new line of HCR™ Verified Tissue products. This innovative tissue resource offers researchers unparalleled accuracy and confidence in RNA-based experiments, enabling breakthroughs in molecular diagnostics, cancer research, and gene expression studies.

Biochain's qRNA tissue sections are uniquely validated for RNA quality using MI's' HCR™ Pro RNA-ISH assay. Unlike standard tissue samples that may not guarantee RNA quality, qRNA allows researchers to confidently assess RNA integrity before conducting their ISH or ISH + IHC co-detection experiments, reducing variability and increasing reproducibility in downstream applications.

The quality of RNA within tissue samples is critical for researchers conducting RNA-based assays to obtain accurate and reproducible results. Using qRNA tissue sections can eliminate concerns about RNA degradation, save time and resources, and enhance the reliability of their experimental outcomes.

Post this

"For researchers conducting RNA-based assays, the quality of RNA within tissue samples is critical for obtaining accurate and reproducible results," says Vidyodhaya Sundaram, PhD, MBA, Vice President of Business Development: Oncology, Liquid Biopsy, Early Cancer Detection and Spatial biology at BioChain . "By using qRNA tissue sections, they can eliminate concerns about RNA degradation, save time and resources, and enhance the reliability of their experimental outcomes. By combining BioChain's extensive biorepository with Molecular Instruments' state-of-the-art detection technologies, we're providing an essential resource for researchers who rely on precise and reliable RNA-based data"

The partnership between BioChain and Molecular Instruments brings together leading expertise in biosample quality assurance and advanced RNA detection technologies. The RNA-ISH Verified Tissue product sets a new standard for biosample integrity through rigorous quality control protocols. Each tissue sample undergoes comprehensive RNA integrity validation, ensuring reliable, high-quality RNA for diverse research and diagnostic workflows.

The validated tissue samples are tailored for a range of advanced applications, including:

  • RNA sequencing (RNA-Seq)
  • In situ hybridization (ISH)
  • Gene expression profiling
  • Molecular diagnostics

"Collaborating with BioChain advances our mission of bringing clinical-grade assay performance to all research users. Developing next-generation assays requires working with sample tissue that is both high quality and easily validated," said Dr. Aneesh Acharya, Chief Commercial Officer at Molecular Instruments. "We're thrilled to partner with BioChain to drive an initiative to improve the quality of clinically relevant research across the industry."

Researchers using RNA-based methods often need help with tissue quality, sample degradation, and unreliable RNA yields, which can compromise the validity of their results. RNA-ISH Verified Tissue products are designed to eliminate these obstacles by offering tissue samples that are fully assessed for RNA integrity, enabling more reliable and reproducible results across a range of molecular biology applications.

BioChain Institute and Molecular Instruments are committed to advancing scientific discovery by providing the pharmaceutical industry with best-in-class tools. This co-branded initiative reflects both companies' dedication to fostering innovation in life sciences, biotechnology, and clinical research.

For more information on the HCR™ Verified Tissue products, please visit this website or www.hcrimaging.com.

About BioChain Institutes, Inc.

Trusted by the top 500 global pharmaceutical, biotechnology, and academic leaders for over 25 years, BioChain's biggest advocates are our customers. Advancing accurate disease diagnosis and drug discovery for biomedical professionals, BioChain is here for you every step of the way with high-quality biospecimens, kits, reagents, instruments, and services. To learn more about the company, visit www.biochain.com

About Molecular Instruments, Inc.

Molecular Instruments® (MI) develops and synthesizes kits powered by its innovative HCR™ Platform for bioimaging applications in academic research, drug development, and clinical pathology and diagnostics. MI offers products for automated and manual chromogenic and fluorescence in situ hybridization (ISH) assays, featuring a protease-free workflow, native compatibility with existing IHC/IF assays, and straightforward image analysis. HCR™ Products are designed to be accessible to all researchers with complimentary introductory Starter KIts, free custom probe design, and pricing that makes sense. To learn more about the company, visit www.hcrimaging.com.

Media Contact

Allyson Markey, BioChain Institute Inc., 1 8582471805, [email protected], https://www.biochain.com/

SOURCE BioChain Institute Inc.

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.